Advisory Board

Noah Kroloff, MBA, Principle, NGN Capital

• 17 years healthcare experience
• VP for International Sales & Marketing and Corporate Development at i-Stat Corporation, a publicly-traded medical device company
  • Led Creation of global alliance with Abbott
  • Led $61M alliance with Hewlett-Packard Medical Products Group
• Engagement Manager at McKinsey & Co.
  • Advised leading pharmaceutical and diagnostic companies on R&D management, portfolio strategy, and alliance formation

Debora Spar, Ph.D., Harvard Business School

• Spangler Family Professor of Business Administration
• Studies how firms compete in foreign markets and how government policies shape and constrain their options
• Author of Ruling the Waves: Cycle of Discovery, Chaos, and Wealth from the Compass to the Internet
  • Study of business cycles, identifying the path of future innovations and the natural development from idea to market in a changing world
• Author of The Baby Business: How Money, Science and Politics Drive the Commerce of Conception
  • Analyzes how the "baby business" has developed and ways commerce, politics and technology are likely to interact in and affect this market

Simon Rosenstein, MD, Vice President, Medical Director, Eastern Region, Great-West Healthcare

• Board certified in Internal Medicine and Medical Management
• Chief physician of a large medical group and senior medical director with several health insurers
• Expertise in managed care operations, strategic planning, hospital and health plan utilization management, and financial analysis
• Established "Ask the Doctor" web presence for Physicians Health Services
• Designed and taught Cardiac Disease Prevention Program and Cardiac Rehabilitation and Educational Program
  • Patient educational and risk factor reduction

Bruce F. Basarab, CEO, Basarab Consulting, LLC

• Consultant to publicly-held companies in start-up and turnaround situations
• More than 25 years in the domestic and international pharmaceuticals market
• Senior Vice President, Sales and Marketing, Geneva Pharmaceuticals (a Novartis company)
  • Established a direct sales and marketing organization for this $500 million manufacturer and developer of generic products
  • Improved U.S. generic market share position from number 5 to number 2.
• Vice President of Sales, Pharmaceuticals Division, Ciba-Geigy Corporation
  • Developed launch plans for three new products: Vivelle®, Voltaren XR® and Tegretol XR®
  • Established a separate contract sales organization to provide increased reach and frequency for selected strategically important products